# A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

> **NCT04526119** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Zeria Pharmaceutical** · enrollment: 55 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Acotiamide hydrochloride hydrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04526119
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-22
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04526119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04526119, "A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04526119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*